Identification and validation of urinary metabolite biomarkers for major depressive disorder
about
Urinary Biomarkers of Brain DiseasesResearch on the Pathological Mechanism and Drug Treatment Mechanism of DepressionRisk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkersMaternal Weaning Modulates Emotional Behavior and Regulates the Gut-Brain Axis.Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats.Novel urinary metabolite signature for diagnosing postpartum depressionSex-specific urinary biomarkers for diagnosing bipolar disorder.Berberine ameliorates nonbacterial prostatitis via multi-target metabolic network regulation.Macaques exhibit a naturally-occurring depression similar to humans.Metabolite profiling in posttraumatic stress disorder.Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trialsDifferential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression.Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients.Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis.Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic studyCombined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum.Therapeutic Effects of Chinese Medicine Herb Pair, Huzhang and Guizhi, on Monosodium Urate Crystal-Induced Gouty Arthritis in Rats Revealed by Anti-Inflammatory Assessments and NMR-Based MetabonomicsMicrobiota Modulates Behavior and Protein Kinase C mediated cAMP response element-binding protein SignalingSerum proteomic profiling of major depressive disorder.Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies.Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysisSerum proteomic profiles of depressive subtypesInnovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.Metabolomics strategy reveals therapeutical assessment of limonin on nonbacterial prostatitis.Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine.Short overview on metabolomic approach and redox changes in psychiatric disorders.Plasma lipidomics reveals potential lipid markers of major depressive disorder.Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.Imbalance in amino acid and purine metabolisms at the hypothalamus in inflammation-associated depression by GC-MS.Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers.D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression.GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.Sex differences in gut microbiota in patients with major depressive disorder.Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials.
P2860
Q26769944-977FF47C-72DF-4C41-9355-FC5733722D80Q26786208-19D9DC59-407F-4676-B017-22AE02091132Q27023402-FFF107FA-907B-4CB1-92C8-77C2A86C83B6Q27342472-FECBEE0C-B192-4D34-B8BF-EA579275B320Q30801268-C3DA5326-5E4B-415C-88BA-A109B4538D24Q33614561-5A93BFA0-D0A8-4967-BDA5-8562B212593DQ33704082-5F70F292-85F7-4136-9521-AE23100EC3EFQ34757521-A8C96BB9-682F-486C-B18B-A81216E71313Q35167250-C2B0C866-6828-4C2C-9B93-E26CABF0EE25Q35188855-589CABCF-BC52-4237-BA2A-C4F6CF5FC1D0Q35200833-761B402C-B96F-4C85-8F67-A5E83DB0AE60Q35240539-72016AD8-3E8D-4A01-BF94-D394FC9DEAA8Q35604108-958308D5-0B79-4A22-B405-BAEE6902232CQ35645024-C2070686-F3D3-4504-99A7-3D43BCC3C24FQ35777077-565F59D9-545A-422B-9105-3326BDDF667FQ35848353-ABE815B1-46D1-4368-B8A4-A731212B5813Q35861541-DE87D188-DFC8-4102-A149-8CBFB2AFBE67Q36632940-FB8F1F5B-B309-42AF-843B-583AA0FFE2FBQ37116628-DB0452B8-77A4-4FD2-9FB8-EF7D200E768BQ37347574-8897E997-23BF-4886-A46F-C91047D288CEQ37398383-6B51AAA6-63AF-4A33-B1F7-A4F331E52084Q37648213-E47A41D8-63E0-4E20-99FA-5B26682B4502Q37733240-A66F49DB-B6C8-4457-8654-E667922B50A3Q38366733-94E7D777-67A7-4DD0-9FD2-F56C18720C68Q38830302-BCD95953-68A4-4C3B-8857-3AF1FAB97B00Q39610291-DAFD0BAB-2BF7-49DC-947E-F2050959D38DQ40058836-2E95F041-4FDF-479C-867F-45CBE7A5FCE0Q40613040-4E3FC1C0-CE99-44F9-9E0A-B8D843370B3DQ41548141-4C53CB8C-278F-400E-B000-AE430A3B6AABQ41791000-85C20F16-803F-4CF6-9DF5-6534BB07FE1FQ46511372-FA71EAA9-A803-413D-B490-4089C6A54F5CQ46565524-BED1B761-560B-42ED-B64A-009199AD824EQ47436744-2D2D0245-C6A7-4A42-87B1-8F7107837A18Q47642189-FE8619AA-1B43-4412-9045-54FC4CAB0F14Q47838435-7CF22E36-22E1-4094-BDD2-4892858E1DA0Q48220933-9D7017BD-A979-4C75-8BB4-82B9AFDC83BCQ50635567-3358F87E-54D5-4A6D-828D-6022683B7875Q50663896-C51D81CA-C790-440D-868D-959F3A9A653EQ52665670-FFA95A1B-3712-4C03-A531-18516FDC93F4Q52879696-E7BB7DA6-E3A5-4013-AD0B-CE1A5AA778B3
P2860
Identification and validation of urinary metabolite biomarkers for major depressive disorder
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Identification and validation ...... for major depressive disorder
@ast
Identification and validation ...... for major depressive disorder
@en
type
label
Identification and validation ...... for major depressive disorder
@ast
Identification and validation ...... for major depressive disorder
@en
prefLabel
Identification and validation ...... for major depressive disorder
@ast
Identification and validation ...... for major depressive disorder
@en
P2093
P2860
P356
P1476
Identification and validation ...... for major depressive disorder
@en
P2093
Dezhi Zhou
Huaqing Meng
Jiaju Zhong
Liang Chen
N D Melgiri
Peng Zheng
P2860
P304
P356
10.1074/MCP.M112.021816
P577
2012-10-30T00:00:00Z